News Service

late-breaking news in healthcare

New ATS Guidelines on Home Oxygen Therapy for Children

February 5, 2019

A multidisciplinary panel from the American Thoracic Society (ATS) published an evidence-based clinical practice guideline on home oxygen therapy for children with chronic respiratory conditions.

Home oxygen therapy is often required in children with chronic respiratory conditions. The new ATS guideline document provides evidence-based guidance on the implementation, monitoring, and discontinuation of home oxygen therapy for the pediatric population.

Key recommendations are as follows:

  • The panel strongly recommends in favor of home oxygen therapy for the following conditions complicated by severe chronic hypoxemia: cystic fibrosis and interstitial lung disease.

  • The panel strongly recommends in favor of home oxygen therapy for the following conditions complicated by chronic hypoxemia: bronchopulmonary dysplasia and pulmonary hypertension without congenital heart disease.

  • The panel makes conditional recommendations that suggest prescribing home oxygen therapy for the following conditions: cystic fibrosis with both mild chronic hypoxemia and dyspnea on exertion, sleep-disordered breathing complicated by severe nocturnal hypoxemia, sickle cell disease complicated by severe chronic hypoxemia, and interstitial lung disease with mild chronic hypoxemia and either dyspnea on exertion or desaturation during sleep or exertion.

  • The panel strongly recommends against home oxygen therapy for pediatric patients with pulmonary hypertension with congenital heart disease.

Oxygen saturation levels should be maintained in an acceptable range based on age and the underlying respiratory condition. It is recommended to use pulse oximetry to measure oxygen saturation levels during home oxygen therapy.

 

Hayes D Jr, Wilson KC, Krivchenia K, et al. Home Oxygen Therapy for Children. An Official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med. 2019;199(3):e5-e23. Available at: click here. Accessed February 4, 2019.